SecBot SecBot
Institutional Cluster

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago
Institutional cluster: 4 buyers, 2 sellers (mixed)
Actionable Insight • Neutral

The cluster is dominated by quant funds, which may be responding to price momentum or mean-reversion signals rather than a fundamental catalyst. Monitor for any fundamental catalyst (earnings, product news) that could explain the quant buying.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$15.47
T+0 close · Jun 11, 2026 · via day close
Latest settled
+50.52%
T+60 · $23.29
Vs SPY
+46.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $15.47entry
  2. T+1 · 5mo ago −2.00%α −2.54% · $15.16
  3. T+5 · 5mo ago −8.40%α −8.84% · $14.17
  4. T+20 · 4mo ago −2.71%α −4.61% · $15.05
  5. T+60 · 2mo ago +50.52%α +46.12% · $23.29

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four institutional investors (D.E. Shaw, Citadel, Two Sigma, UBS) significantly increased their MMED positions in Q3 2025, adding a net $9.2M in holdings, while two mega-passive sellers (Morgan Stanley, BofA) trimmed modestly. The cluster is dominated by quantitative funds, suggesting a shared algorithmic or factor-based thesis rather than a fundamental catalyst.

Key Financial Metrics

Direction
accumulating
Buy Value
$11.4M
Sell Value
$6.1M
Net Flow
$7.6M

Institutional Positions

Net institutional flow: $7.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
D.E. ShawDOUBLED+268.1%$2.6M$2.2M
CitadelADD+90.1%$4.0M$2.8M
Two SigmaDOUBLED+424.9%$3.5M$3.1M
Ubs Am, A Distinct Business UnDOUBLED+178.3%$1.4M$1.1M

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-28%$4.5M-$1.4M
BofATRIM-29.5%$774.0K-$217.0K

Key Facts

  • 4 buyers added $9.2M in net new holdings; 2 sellers reduced by $1.6M (net cluster inflow ~$7.6M).
  • Three of four buyers are quantitative funds (D.E. Shaw, Citadel, Two Sigma), signal may be factor-driven, not fundamental.
  • Morgan Stanley and BofA trimmed ~28-30% of their positions, but their dollar values increased due to stock price appreciation.
  • Total institutional buying ($11.4M current holdings) is ~0.3% of MMED's $4.1B market cap, modest scale.

Financial Impact

Net institutional inflow of approximately $7.6M (buyers added $9.2M, sellers reduced $1.6M), representing about 0.2% of market cap.

institutional ownershipfloat turnover

Risk Factors

  • Quantitative buying may be short-term and already unwound given the 45-day 13F reporting lag.
  • Passive selling by Morgan Stanley and BofA could indicate index rebalancing or risk reduction.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MMED-2025-Q3

US Market Status

Market Closed · Opens Wed (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026